General Information
Sangamo Neuropathy 0901
A Phase 2B Repeat Dosing Clinical Trial of (study drug) in Subjects with Moderately Severe Diabetic Neuropathy
| Protocol | SB-509-0901 |
|---|---|
| Identifier | SB-509-0901 |
| UID | 95d77c00-0415-4e1f-a577-76cfab5a509c |
| Status | Done - Archived |
| Phase | 2B |
| Category | Diabetic Neuropathy / Adult |
| Launch Year | 2010 |
| NCT Number | - |
| Created | 2010-06-01 18:04 |
| Last Updated | 2010-06-01 18:04 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2010-04-02 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2012-01-30 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Unger, Jeffrey | JUnger | No |
| Recruiter | - | No | |
| Coordinator | Mercado, Michelle | MMercado | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Sangamo BioSciences, Inc |
|---|---|
| Division | Sangamo BioSciences, INc |
| Team | Sangamo BioSciences, INc |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
